acridines has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahadorikhalili, S; Bandarian, F; Faramarzi, MA; Imanparast, S; Khalifeh, R; Larijani, B; Mahdavi, M; Mohammadi-Khanaposhtani, M; Nasli Esfahani, E; Rezaei, S; Safavi, M | 1 |
Chang, FY; Shaio, MF | 1 |
2 other study(ies) available for acridines and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
Topics: Acridines; alpha-Glucosidases; Binding Sites; Catalytic Domain; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Drug Design; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship; Thioacetamide | 2018 |
Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics.
Topics: Acridines; Adult; Aged; Cefotaxime; Chemotaxis, Leukocyte; Diabetes Mellitus, Type 2; Female; Humans; Luminescent Measurements; Male; Middle Aged; Neutrophils; Oxygen Consumption | 1990 |